Playback speed
10 seconds
ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRAS, Recurrent/Metastatic HNSCC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Alan Ho
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Alan Ho
97 views
November 24, 2023
Login to view comments.
Click here to Login